首页 > 市场调查报告书 > 医疗设备

体外诊断

感染疾病诊断市场规模、份额和成长分析：按检体类型、产品类型、检测类型、疾病类型、技术、最终用户和地区划分 - 2026-2033 年行业预测

市场调查报告书

商品编码

1973579

感染疾病诊断市场规模、份额和成长分析：按检体类型、产品类型、检测类型、疾病类型、技术、最终用户和地区划分 - 2026-2033 年行业预测

Infectious Disease Diagnostics Market Size, Share, and Growth Analysis, By Sample Type (Blood, Serum), By Product, By Testing Type, By Disease Type, By Technology, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月27日 | 出版商:

SkyQuest | 英文 186 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2024年全球感染疾病诊断市值为229.4亿美元，预计将从2025年的248.2亿美元成长到2033年的466.3亿美元。预测期（2026-2033年）的复合年增长率预计为8.2%。

受感染疾病流行率上升和分子诊断技术进步的推动，全球感染疾病诊断市场正经历显着成长。远距远端医疗的普及、就地检验需求的显着增长以及公众对感染疾病认识的提高，都为这一增长提供了动力。爱滋病、结核病和病毒感染疾病爆发等新出现的健康威胁正在推动市场扩张，而PCR、次世代定序（NGS）和基于CRISPR的诊断技术等创新在其中发挥关键作用。便利性、快速出结果和低基础设施需求是照护现场解决方案广受欢迎的原因。诊断公司与数位医疗公司之间的合作正在改善物流，而远端医疗服务的兴起则满足了日益增长的居家检测需求。然而，高成本、监管挑战和基础设施限制可能会阻碍市场更广泛的渗透。

全球感染疾病诊断市场按产品、检测类型、检体类型、疾病类型、技术、最终用户和地区进行细分。依产品划分，市场分为试剂、试剂盒及耗材、仪器、软体及服务。按检测类型划分，市场分为检查室检测和即时检测（POC）。依检体类型划分，市场分为血液、血清和血浆、尿液以及其他检体类型。依疾病类型划分，市场分为肝炎、爱滋病、医院感染、蚊媒疾病、人类乳突病毒（HPV）、披衣菌感染披衣菌、淋病、结核病、流感、梅毒等感染疾病。依技术划分，市场分为免疫诊断、临床微生物学、聚合酵素链锁反应（PCR）、恒温核酸增幅技术、DNA定序和次世代定序、DNA微阵列等技术。按最终用户划分，可分为诊断检查室、医院和诊所、学术研究机构以及其他最终用户。依地区划分，可分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

推动全球感染疾病诊断市场发展的因素

全球感染疾病诊断市场的主要驱动因素之一是感染疾病的日益普及和公众健康意识的提高。随着包括呼吸道感染疾病、性行为感染感染和虫媒感染疾病在内的各种感染疾病率的上升，对快速、准确的诊断工具的需求也日益增长。此外，分子检测和就地检验设备等诊断技术的进步，有助于及时诊断并改善患者预后。各国政府和相关组织加大对医疗基础设施和研究活动的投入，致力于加强感染疾病防治措施，进一步推动了市场的发展。

全球感染疾病诊断市场面临的限制因素

全球感染疾病诊断市场的主要限制因素之一是先进诊断技术和设备的高成本。尤其是在发展中地区，许多医疗机构无法拨出足够的预算来购买和维护最先进的诊断工具，这限制了患者获得全面检测的机会。此外，严格的监管要求和冗长的核准流程也减缓了新诊断测试的市场推广速度，阻碍了市场成长。在某些地区，操作先进诊断系统的熟练人员短缺也是一个挑战，最终影响感染疾病防治的整体效率和效果。

全球感染疾病诊断市场趋势

在全球感染疾病诊断市场，一个显着的趋势是采用多重检测和综合征检测组合，这种组合能够同时从单一检体中检测多种感染疾病。这项创新技术在呼吸道感染、胃肠道感染和性行为感染感染疾病的诊断方面尤其引人注目，并且在急诊室、加护病房等关键医疗机构以及感染疾病爆发期间发挥着极其重要的作用。随着医疗机构优先考虑成本效益和简化工作流程，对这些先进多重检测组合的需求预计将快速增长，感染疾病管理领域也明显转向全面、快速的诊断解决方案。

北美洲
- 我们
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场公司采取的策略
近期市场趋势
企业市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 按细分市场进行企业市占率分析
- 2023-2025年营收年比比较

主要企业简介

F. Hoffmann-La Roche Ltd.
Abbott
bioMerieux
Siemens Healthineers AG
Danaher
Thermo Fisher Scientific Inc.
Hologic, Inc.
Becton, Dickinson and Company
Qiagen
Seegene Inc.
Grifols, SA
DiaSorin SpA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Co-Diagnostics, Inc.
Trinity Biotech
Genetic Signatures Ltd.
QuidelOrtho Corporation
Revvity
OraSure Technologies

结论与建议

简介目录

Product Code: SQMIG35D2341

Global Infectious Disease Diagnostics Market size was valued at USD 22.94 Billion in 2024 and is poised to grow from USD 24.82 Billion in 2025 to USD 46.63 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global infectious disease diagnostics market is experiencing significant growth, driven by a rise in the prevalence of infectious diseases and advancements in molecular diagnostics. There is a notable demand for point-of-care testing and heightened awareness of infectious diseases, alongside the increased adoption of telemedicine. Emerging health threats like HIV, tuberculosis, and viral outbreaks stimulate market expansion, with innovations in technologies such as PCR, NGS, and CRISPR-based diagnostics playing a crucial role. The appeal of convenience, rapid results, and minimal infrastructure requirements enhances the popularity of point-of-care solutions. Collaborations between diagnostic companies and digital health firms improve logistics, while the rise of telehealth services meets growing demands for at-home testing. However, high costs, regulatory challenges, and infrastructure limitations may hinder broader market penetration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Disease Diagnostics Market Segments Analysis

Global infectious disease diagnostics market is segmented by product, testing type, sample type, disease type, technology, end user and region. Based on product, the market is segmented into reagents, kits, and consumables, instruments, and software & services. Based on testing type, the market is segmented into laboratory testing and POC Testing. Based on sample type, the market is segmented into blood, serum, and plasma, urine and other sample types. Based on disease type, the market is segmented into hepatitis, HIV, hospital-acquired infections, mosquito-borne diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis, and other infectious diseases. Based on technology, the market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing, DNA microarray, and other technologies. Based on end user, the market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Infectious Disease Diagnostics Market

One of the key market drivers for the global infectious disease diagnostics market is the increasing prevalence of infectious diseases coupled with rising public health awareness. With the growing incidence of various infectious diseases like respiratory infections, sexually transmitted diseases, and vector-borne diseases, there is a heightened demand for rapid and accurate diagnostic tools. Additionally, advancements in diagnostic technologies, such as molecular testing and point-of-care devices, are facilitating timely diagnoses and better patient outcomes. Increased investment in healthcare infrastructure and research initiatives further propels the market, as governments and organizations focus on combating infectious diseases more effectively.

Restraints in the Global Infectious Disease Diagnostics Market

One significant market restraint for the Global Infectious Disease Diagnostics Market is the high cost associated with advanced diagnostic technologies and equipment. Many healthcare facilities, particularly in developing regions, struggle to allocate sufficient budgets for purchasing and maintaining state-of-the-art diagnostic tools, which limits access to comprehensive testing. Additionally, stringent regulatory requirements and lengthy approval processes can delay the introduction of new diagnostic tests to the market, further hampering growth. The lack of skilled personnel to operate sophisticated diagnostic systems in certain areas also poses a challenge, ultimately affecting the overall efficiency and effectiveness of infectious disease management.

Market Trends of the Global Infectious Disease Diagnostics Market

The Global Infectious Disease Diagnostics market is witnessing a significant trend towards the adoption of multiplex and syndromic testing panels, which enable the simultaneous detection of multiple pathogens from a single sample. This innovation is gaining traction, especially for diagnosing respiratory, gastrointestinal, and sexually transmitted infections, making it highly valuable in critical healthcare settings such as emergency departments and intensive care units, as well as during outbreak situations. As healthcare facilities increasingly prioritize cost-efficiency and streamline workflows, the demand for these advanced multiplex molecular panels is poised for accelerated growth, highlighting a shift towards comprehensive and rapid diagnostic solutions in infectious disease management.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Infectious Disease Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Reagents & Kits
Instruments
Software & Services

Global Infectious Disease Diagnostics Market Size by Testing Type & CAGR (2026-2033)

Market Overview
Laboratory Testing
Point-of-Care Testing

Global Infectious Disease Diagnostics Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Blood & Plasma
Urine
Other Samples

Global Infectious Disease Diagnostics Market Size by Disease Type & CAGR (2026-2033)

Market Overview
Hepatitis
HIV
Tuberculosis
Influenza
Other Infectious Diseases
- Hospital-Acquired Infections
- Mosquito-Borne Diseases
- HPV
- Chlamydia
- Gonorrhea
- Syphilis

Global Infectious Disease Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunodiagnostics
Clinical Microbiology
Nucleic Acid Amplification
- Polymerase Chain Reaction
- Isothermal Amplification
DNA Technologies
- Sequencing
- Microarray

Global Infectious Disease Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Research Institutes
Other End Users

Global Infectious Disease Diagnostics Market Size & CAGR (2026-2033)

North America (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- US
- Canada
Europe (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Co-Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genetic Signatures Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments